Company intelligence / Profile preview

BrainGate

Providence, Boston, Rhode Island, Massachusetts, USAbraingate.org ↗

Ownership: Private
Development stage: Clinical

Overview

The BrainGate system has enabled people with tetraplegia to control computer cursors, robotic arms, and other assistive devices using only their thoughts. Multiple clinical studies have demonstrated proof-of-concept for restoring communication and some functional independence to individuals with severe motor impairments.

Therapeutic areas: Neurology
Modalities: DeviceNeurotechnologyMicroelectrode array implant
Industry: Academic Hospital/University/Research

Partnerships

Brown UniversityMassachusetts General HospitalEmory University

Beyond the preview

Go deeper on BrainGate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BrainGate.

Explore the full profile